Wim Quint
Overview
Explore the profile of Wim Quint including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
5663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Nestosa M, Sanchez D, Canete-Portillo S, Alemany L, Clavero O, Lloveras B, et al.
Int J Surg Pathol
. 2024 Nov;
:10668969241295352.
PMID: 39535004
Squamous cell carcinomas with two or more coexisting clearly different histological subtypes of penile carcinomas are designated as mixed carcinomas in current classification models. They represent about 10% of all...
2.
Ahmed S, Befano B, Lemay A, Egemen D, Rodriguez A, Angara S, et al.
Sci Rep
. 2023 Dec;
13(1):21772.
PMID: 38066031
Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening...
3.
Sanchez D, Fernandez-Nestosa M, Alemany L, Canete-Portillo S, Lloveras B, Clavero O, et al.
Hum Pathol
. 2023 Jul;
139:65-72.
PMID: 37429448
Human papillomavirus (HPV) is detected in 30-50% of invasive penile carcinomas, and it is frequently associated with basaloid and warty morphological features. Based on this heterogeneity and different clinical behaviors,...
4.
Ahmed S, Befano B, Lemay A, Egemen D, Rodriguez A, Angara S, et al.
Res Sq
. 2023 Mar;
PMID: 36909463
Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening...
5.
Mena M, Wang X, Tous S, Quiros B, Clavero O, Alejo M, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954451
Background: Tests or test algorithms for diagnosing HPV-driven oral cavity and laryngeal head and neck carcinomas (HNC) have not been yet validated, and the differences among oral cavity and laryngeal...
6.
Sierra M, Tsang S, Porras C, Herrero R, Sampson J, Cortes B, et al.
Sex Transm Infect
. 2022 Jul;
PMID: 35842229
Introduction: Human papillomavirus (HPV) vaccines protect against incident HPV infections, which cause cervical cancer. Objectives: We estimated the prevalence and incidence of HPV infections in young adult women to understand...
7.
Hu S, Kreimer A, Porras C, Guillen D, Alfaro M, Darragh T, et al.
J Natl Cancer Inst
. 2022 May;
114(9):1253-1261.
PMID: 35640980
Background: We investigated the impact of human papillomavirus (HPV) vaccination on the performance of cytology-based and HPV-based screening for detection of cervical precancer among women vaccinated as young adults and...
8.
Pedersen H, Ejegod D, Quint W, Xu L, Arbyn M, Bonde J
J Mol Diagn
. 2022 Feb;
24(4):365-373.
PMID: 35123039
The clinical performance evaluation of the novel MassARRAY human papillomavirus (MA-HPV) assay was performed using Danish SurePath cervical cancer screening samples under the fourth Validation of HPV Genotyping Tests (VALGENT)...
9.
Bhatia R, Alcaniz Boada E, Bonde J, Quint W, Christiansen I, Xu L, et al.
J Virol Methods
. 2021 Apr;
294:114161.
PMID: 33895238
Aim: The VALidation of HPV GENotyping Tests (VALGENT) is a framework for comparison and validation of HPV tests with genotyping capabilities. In this study, the clinical performance of a single...
10.
Ejegod D, Pedersen H, Quint W, Xu L, Arbyn M, Bonde J
J Virol Methods
. 2021 Mar;
292:114118.
PMID: 33766660
The CLART HPV4S (CLART4S) is a novel full genotyping assay, based on PCR/microarray technology. We assessed the clinical accuracy of the CLART4S assays under the fourth installment of the VALGENT...